The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. APMPLMI. 2022;3(1):1-10. doi:10.52914/apmp.v3i1.42